CAS
LEGN icon

Coppell Advisory Solutions’s Legend Biotech LEGN Stock Holding History

Coppell Advisory Solutions’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-297
Closed -$18.3K – 1176
2024
Q4 		$18.3K Hold
297
– – ﹤0.01% 916
2024
Q3 		$18.3K Hold
297
– – ﹤0.01% 905
2024
Q2 		$18.3K Buy
+297
New +$13.7K ﹤0.01% 826
2023
Q4 		$18.3K Buy
+297
New +$18.8K ﹤0.01% 766
2023
Q3 		– Sell
-586
Closed -$41.1K – 1395
2023
Q2 		$41.1K Buy
+586
New +$38.3K 0.01% 443

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Coppell Advisory Solutions's LEGN Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 297 shares — an estimated $18.3K sold.

Coppell Advisory Solutions first reported a position in LEGN in Q2 2023 and held it in 5 quarters. The position peaked at $41.1K in Q2 2023. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 297 Legend Biotech shares in Q1 2025, an estimated $18.3K.
  • Coppell Advisory Solutions first reported a position in Legend Biotech in Q2 2023 and held it in 5 quarters.
  • Coppell Advisory Solutions's Legend Biotech position peaked at $41.1K in Q2 2023.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.